FDA Import Refusal 112-2483508-7/1/1 — Glaxosmithkline Pharmaceuticals
The FDA refused shipment 112-2483508-7/1/1 from Glaxosmithkline Pharmaceuticals (United Kingdom) on Aug 23, 2011. The refused product falls under Drugs and Biologics — LAMOTRIGINE (ANTI-CONVULSANT). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Aug 23, 2011
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 61MIA38 LAMOTRIGINE (ANTI-CONVULSANT)
- Charges
- 118,75